Brooks Automation

Brooks Automation is a prominent global provider of automation, vacuum, and instrumentation solutions primarily for the semiconductor manufacturing and life sciences industries. Founded in 1978, the company has evolved from a specialist in robotics for wafer handling into a diversified technology firm serving critical, controlled environments. Its products are essential for the production of advanced integrated circuits and for supporting research in biotechnology and pharmaceutical development.

History

The company was established in 1978 by engineers Robert J. Therrien and John R. Uzzola in Chelmsford, Massachusetts, initially focusing on precision robotic systems for handling silicon wafers in the burgeoning semiconductor industry. A significant early milestone was the development of atmospheric robotic arms that operated within equipment front end modules (EFEM), becoming an industry standard. Throughout the 1980s and 1990s, Brooks Automation expanded its technological footprint, supporting the industry's transition to larger 300 mm wafer standards and the increasing complexity of fab automation. In the 2000s, the company strategically entered the life sciences market, acquiring firms like RTS Life Science to provide cold chain and sample management solutions for biobanks and pharmaceutical companies.

Products and Services

The company's portfolio is divided into two core segments: Semiconductor Solutions and Life Sciences. The Semiconductor Solutions group offers sophisticated robotics, linear motors, and atmospheric and vacuum transfer modules essential for moving wafers between process tools in a cleanroom. This includes integrated factory automation software and contamination control systems. The Life Sciences segment provides automated cold storage systems, biological sample repositories, and software platforms for managing clinical trial samples and genomic data. Key products include the Cryo Store automated freezer and the Sample Management informatics suite, which are critical for research institutions like the Broad Institute and pharmaceutical giants such as Pfizer.

Acquisitions and Divestitures

Brooks Automation has grown significantly through a deliberate strategy of mergers and acquisitions. Notable acquisitions to bolster its semiconductor capabilities include Helix Technology in 2005, a leader in cryogenic pumps, and Crossing Automation in 2012. For its life sciences division, key purchases were RTS Life Science in 2007, BioStorage Technologies in 2011, and GENEWIZ in 2018, a major genomic sequencing service provider. A major corporate transformation occurred in 2021 when Brooks Automation announced the separation of its two business units. The Semiconductor Solutions group was sold to Thomas H. Lee Partners and became an independent company named Brooks Instrument, while the Life Sciences business was spun off and merged with Altaris Capital Partners' portfolio company to form Azenta, Inc..

Corporate Structure and Operations

Following the 2021 separation, the legacy Brooks Automation corporate entity effectively ceased to exist as its two major divisions became independent, publicly traded companies. The former Semiconductor Solutions business, operating as Brooks Instrument, maintains its headquarters in Chelmsford, Massachusetts, and continues to design and manufacture its precision automation and vacuum products for the global semiconductor market. The former Life Sciences business, now operating as Azenta, Inc., is also headquartered in Chelmsford and manages a worldwide network of sample storage facilities and service laboratories. Both successor entities maintain significant research and development operations and manufacturing sites across North America, Europe, and Asia.

Industry and Market Position

Within the semiconductor equipment sector, the former Brooks Automation was a leading supplier of wafer fab automation and contamination control solutions, competing directly with firms like Murata Machinery and Daifuku Co., Ltd.. Its technology was integral to the production lines of major chipmakers including Intel, Taiwan Semiconductor Manufacturing Company (TSMC), and Samsung Electronics. In the life sciences tools market, its successor, Azenta, Inc., holds a strong position in the automated biorepository and genomic services space, competing with companies such as Thermo Fisher Scientific and BioLife Solutions. The company's evolution reflects broader industrial trends toward increased automation and data management in both microelectronics and biopharmaceutical research.

Category:American companies established in 1978 Category:Semiconductor industry Category:Life sciences industry